Madison Dearborn Partners to acquire Walgreens Infusion Services
Madison Dearborn Partners has agreed to buy a majority stake in Walgreens Infusion Services, a provider of home and alternate treatment site infusion services. No financial terms were disclosed for the transaction that is expected to close during the second quarter of calendar 2015. BofA Merrill Lynch provided financial advice to Walgreen Co. while Barclays, Deutsche Bank and Goldman Sachs advised MDP.






